Wang Hong, Zhang Zhi-Qiang, Wang Shu-Zhen, Lu Jun-Li, Wang Xiao-Lan, Zhang Zhen-Yu
Department of Obstetrics and Gynecology, Beijing Chaoyang Hospital, The Affiliated Hospital of Capital Medical University, Beijing, China.
Department of Obstetrics and Gynecology, China Meitan General Hospital, Beijing, China.
J Obstet Gynaecol Res. 2015 Dec;41(12):1972-81. doi: 10.1111/jog.12809. Epub 2015 Sep 30.
The aim of this study was to explore the correlation between genetic mutations in matrix metalloproteinase-10 (MMP-10) and susceptibility to pelvic organ prolapse (POP).
From September 2011 to December 2013, 263 subjects were recruited, including 91 patients with POP (case group) and 172 non-POP patients (control group). Total MMP-10 concentrations in serum were measured by enzyme-linked immunosorbent assay. The genotyping of MMP-10 was achieved by quantitative real-time polymerase chain reaction. All data were analyzed with SPSS 18.0.
We found that parity, menopause, history of total hysterectomy, and family history of POP were all significantly higher in the POP group than in the control group (P = 0.017, P = 0.046, P = 0.0029 and P < 0.001, respectively). Serum MMP-10 levels were obviously higher in the POP group than in the control group (P < 0.05). In addition, there was a statistically significant difference between the two groups in the distribution frequency of the MMP-10 (rs17435959G/C) genotype (P < 0.05). However, the distribution frequency of the MMP-10 (rs17293607C/T) genotype between the two groups showed no significant differences (P > 0.05). Furthermore, the patients with parity > 2 and postmenopausal women had elevated serum MMP-10 levels, and the patients with parity > 2 and postmenopausal women who carried the G/C + C/C genotype in the MMP-10 gene had an increased risk of POP.
We support the view that the rs17435959 polymorphism of the MMP-10 gene may be associated with an increased risk of POP.
本研究旨在探讨基质金属蛋白酶-10(MMP-10)基因突变与盆腔器官脱垂(POP)易感性之间的相关性。
2011年9月至2013年12月,招募了263名受试者,包括91例POP患者(病例组)和172例非POP患者(对照组)。采用酶联免疫吸附测定法检测血清中MMP-10的总浓度。通过定量实时聚合酶链反应进行MMP-10的基因分型。所有数据均用SPSS 18.0进行分析。
我们发现,POP组的产次、绝经、全子宫切除史和POP家族史均显著高于对照组(分别为P = 0.017、P = 0.046、P = 0.0029和P < 0.001)。POP组血清MMP-10水平明显高于对照组(P < 0.05)。此外,两组间MMP-10(rs17435959G/C)基因型的分布频率存在统计学显著差异(P < 0.05)。然而,两组间MMP-10(rs17293607C/T)基因型的分布频率无显著差异(P > 0.05)。此外,产次>2的患者和绝经后女性血清MMP-10水平升高,产次>2且携带MMP-10基因G/C + C/C基因型的绝经后女性患POP的风险增加。
我们支持MMP-10基因的rs17435959多态性可能与POP风险增加相关的观点。